Cookies: We use cookies to give you the best possible experience on our site. By continuing to use the site you agree to our use of cookies. Find out more
House of Commons Hansard
x
Blood: Contamination
08 March 2010
Volume 507
The edit just sent has not been saved. The following error was returned:
This content has already been edited and is awaiting review.

To ask the Secretary of State for Health what estimate his Department has made of the cost of compensation to people who have contracted (a) HIV, (b) hepatitis C and (c) other infections from NHS-supplied contaminated blood. [320871]

The edit just sent has not been saved. The following error was returned:
This content has already been edited and is awaiting review.

The Government currently make ex-gratia payments to those infected with HIV by contaminated national health service blood and blood products through the Macfarlane and Eileen Trusts (in 2010-11 the two Trusts became MFET Ltd), and to those infected with hepatitis-C by contaminated NHS blood and blood products through the Skipton Fund. Based on expenditure in 2009-10, it is estimated that £5.13 million will be made available for non-discretionary payments through MFET Ltd, and £2.47 million will be made available for discretionary payments through MFET Ltd in 2010-11. It is estimated that £5 million will be made available for payments through the Skipton Fund, in 2010-11. To date, nearly £150 million has been paid out through these mechanisms.

Compensation to all those infected with variant Creutzfeldt Jakob disease (vCJD), including those who are thought to have been infected by contaminated blood transfusions, is provided through the vCJD Trust. The size of the Trust fund has been fixed at £67.5 million to compensate the first 250 patients and their families. Up to 5 April 2009, the vCJD trust has disbursed approximately £38 million.